You are subscribed to What's New at CBER for U.S. Food & Drug Administration (FDA).
This page has been updated recently.
Public Workshop - Strategies to Address Hemolytic Complications of Immune Globulin Infusions - Agenda (PDF - 47KB)
Updated: 01/31/2014
February 28, 2014: Vaccines and Related Biological Products Advisory Committee Meeting Announcement
Posted: 01/31/2014
| This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
